BR9915520A - Antagonistas receptores ccr-3 derivados de pirrolidina - Google Patents
Antagonistas receptores ccr-3 derivados de pirrolidinaInfo
- Publication number
- BR9915520A BR9915520A BR9915520-6A BR9915520A BR9915520A BR 9915520 A BR9915520 A BR 9915520A BR 9915520 A BR9915520 A BR 9915520A BR 9915520 A BR9915520 A BR 9915520A
- Authority
- BR
- Brazil
- Prior art keywords
- carbon atoms
- ccr
- receptor antagonists
- alkylene
- group selected
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Patente de Invenção: <B>"ANTAGONISTAS RECEPTORES CCR-3 DERIVADOS DE PIRROLIDINA"<D>. Esta invenção refere-se a certos derivados de 3-aminometil-pirrolidina da fórmula (I) onde: Z é -N- ou -(N^ +^r)- X^ -^ onde R é alquila, haloalquila, aralquila, hidroxialquila, carboxialquila, alcoxicarbonilalquila ou cianoalquila, e X^ -^ é um contra-íon farmaceuticamente aceitável; Ar^ 1^ e Ar^ 2^ são, independentemente um do outro, arila ou heteroarila; Q é um alquileno reto ou ramificado com 1-3 átomos de carbono; R^ 1^ é hidrogênio ou alquila; A é ou: (I) -N(R^ 2^)C(O)- quando: B é: (i) um alquileno com 1-4 átomos de carbono inclusive onde um dos átomos de carbono pode ser opcionalmente substituído por um grupo selecionado de -C(O)-, -N(R^ 4^)-, -O-, -S(O)~ n~- (onde n é 0, 1 ou 2), NR^ 5^C(O)- e N(R^ 6^)SO~ 2~-; ou (ii) uma cadeia alquinileno; ou (II) um grupo selecionado de -N(R^ 2^)C(S)-, -N(R^ 2^)C(O)N(R^ 3^)-, -N(R^ 2^)C(S)N(R^ 3^)-, -N(R^ 2^)SO~ 2~-, -N(R^ 2^)SO~ 2~N(R^ 3^)-, -N(R2)C(O)O- e OC(O)N(R~ 3~)- quando: B é: (i) uma ligação; (ii) uma cadeia alquileno de 1-4 átomos de carbono inclusive onde um dos átomos de carbono pode opcionalmente ser substituídos por um grupo selecionado de -C(O)-, N(R^ 4^)-, -O-, -S(O)n- onde n é 0, 1 ou 2), - NR^ 5^C(O)- 2 e N(R^ 6^)SO~ 2~-; (iii) uma cadeia alquenileno; ou (iv) uma cadeia alquinileno; que são antagonistas receptores de CCR-3, composições farmacêuticas contendo-os, métodos para o seu uso e métodos para a preparação desses composto.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10929798P | 1998-11-20 | 1998-11-20 | |
PCT/EP1999/008665 WO2000031032A1 (en) | 1998-11-20 | 1999-11-11 | Pyrrolidine derivatives-ccr-3 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9915520A true BR9915520A (pt) | 2001-07-17 |
Family
ID=22326918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9915520-6A BR9915520A (pt) | 1998-11-20 | 1999-11-11 | Antagonistas receptores ccr-3 derivados de pirrolidina |
Country Status (27)
Country | Link |
---|---|
US (1) | US6166015A (pt) |
EP (1) | EP1131288A1 (pt) |
JP (1) | JP3593037B2 (pt) |
KR (1) | KR20010086045A (pt) |
CN (1) | CN1158256C (pt) |
AR (1) | AR023707A1 (pt) |
AU (1) | AU763960B2 (pt) |
BR (1) | BR9915520A (pt) |
CA (1) | CA2350903A1 (pt) |
CO (1) | CO5140119A1 (pt) |
CZ (1) | CZ20011760A3 (pt) |
DE (1) | DE19955794A1 (pt) |
ES (1) | ES2158814B1 (pt) |
FR (1) | FR2786185A1 (pt) |
GB (1) | GB2343893B (pt) |
HU (1) | HUP0104364A2 (pt) |
ID (1) | ID29067A (pt) |
IL (1) | IL143226A0 (pt) |
IT (1) | IT1307900B1 (pt) |
MA (1) | MA26762A1 (pt) |
NO (1) | NO20012411L (pt) |
PE (1) | PE20001403A1 (pt) |
PL (1) | PL348375A1 (pt) |
TR (1) | TR200101398T2 (pt) |
UY (1) | UY25811A1 (pt) |
WO (1) | WO2000031032A1 (pt) |
ZA (1) | ZA200103942B (pt) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL125658A0 (en) | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
US6339087B1 (en) | 1997-08-18 | 2002-01-15 | Syntex (U.S.A.) Llc | Cyclic amine derivatives-CCR-3 receptor antagonists |
US6316623B1 (en) * | 1998-08-21 | 2001-11-13 | Isis Pharmaceuticals, Inc. | Ethylenediamine compound libraries |
DE69938193D1 (de) | 1998-11-20 | 2008-04-03 | Hoffmann La Roche | Piperidin ccr-3 rezeptor-hemmer |
CA2373942A1 (en) * | 1999-05-18 | 2000-11-23 | Teijin Limited | Remedies or prophylactis for diseases in association with chemokines |
KR100667645B1 (ko) * | 1999-08-04 | 2007-02-28 | 데이진 가부시키가이샤 | 환상 아민 ccr3 길항제 |
CN1208318C (zh) * | 1999-12-08 | 2005-06-29 | 帝人株式会社 | 环胺ccr5受体拮抗剂 |
AU2001290146A1 (en) * | 2000-09-29 | 2002-04-08 | Glaxo Group Limited | Compounds useful in the treatment of inflammatory diseases |
AR035205A1 (es) | 2000-09-29 | 2004-05-05 | Glaxo Group Ltd | Compuestos utiles en el tratamiento de enfermedades inflamatorias, proceso para su preparacion, intermediarios y composiciones farmaceuticas |
BR0116352A (pt) * | 2000-12-19 | 2003-12-02 | Hoffmann La Roche | Pirrolidinas substituìdas como antagonistas de receptor ccr-3 |
FR2821356A1 (fr) | 2001-02-23 | 2002-08-30 | Cerep | Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations |
GB0117387D0 (en) * | 2001-07-17 | 2001-09-05 | Novartis Ag | Organic compounds |
CN1267412C (zh) * | 2001-09-13 | 2006-08-02 | 霍夫曼-拉罗奇有限公司 | Ccr-3受体拮抗剂v |
US7067549B2 (en) * | 2001-12-31 | 2006-06-27 | Actelion Pharmaceuticals Ag | Pyrrolidone carboxamides |
GB0207439D0 (en) * | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
GB0207436D0 (en) * | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
GB0207432D0 (en) | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
GB0207443D0 (en) * | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
GB0212355D0 (en) * | 2002-05-29 | 2002-07-10 | Glaxo Group Ltd | Novel compounds |
CN1867336B (zh) | 2002-06-12 | 2010-05-12 | 凯莫森特里克斯股份有限公司 | 1-芳基-4-取代的哌嗪衍生物及其制药用途 |
US7842693B2 (en) | 2002-06-12 | 2010-11-30 | Chemocentryx, Inc. | Substituted piperazines |
US7589199B2 (en) | 2002-06-12 | 2009-09-15 | Chemocentryx, Inc. | Substituted piperazines |
JP2006502107A (ja) | 2002-07-02 | 2006-01-19 | エフ.ホフマン−ラ ロシュ アーゲー | Ccr−3レセプターアンタゴニストixとしての2,5−置換ピリミジン誘導体 |
US6919356B2 (en) * | 2002-09-26 | 2005-07-19 | Bristol Myers Squibb Company | N-substituted heterocyclic amines as modulators of chemokine receptor activity |
EP1603899B1 (en) | 2003-03-06 | 2009-08-26 | Glaxo Group Limited | Heterocyclic urea derivatives for the treatment of pain |
US7514562B2 (en) | 2003-03-07 | 2009-04-07 | Glaxo Group Limited | Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain |
GB0305426D0 (en) * | 2003-03-08 | 2003-04-16 | Glaxo Group Ltd | Novel compounds |
CA2517888C (en) | 2003-03-14 | 2012-05-01 | Ono Pharmaceutical Co., Ltd. | Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
JP4710606B2 (ja) | 2003-04-18 | 2011-06-29 | 小野薬品工業株式会社 | スピロピペリジン化合物およびその医薬用途 |
RU2006117631A (ru) * | 2003-10-24 | 2007-12-10 | Ф.Хоффманн-Ля Рош Аг (Ch) | Антагонисты рецептора ссr3 |
AU2005219438B2 (en) | 2004-03-03 | 2011-02-17 | Chemocentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
US7435831B2 (en) | 2004-03-03 | 2008-10-14 | Chemocentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
NZ551196A (en) * | 2004-05-14 | 2010-08-27 | Emisphere Tech Inc | Compounds and compositions for delivering active agents |
TWI400232B (zh) | 2004-09-13 | 2013-07-01 | Ono Pharmaceutical Co | 含氮雜環衍生物及以該含氮雜環衍生物為有效成分之藥劑 |
WO2006088541A2 (en) | 2005-02-17 | 2006-08-24 | State Of Oregon Acting By & Through The State Board Of Higher Edu. On Behalf Of Portland State Unv. | Quinoline derivatives and uses thereof |
US20110052612A1 (en) | 2005-05-31 | 2011-03-03 | Ono Pharmaceutical Co., Ltd. | Spiropiperidine compound and medicinal use thereof |
WO2007011292A1 (en) * | 2005-07-21 | 2007-01-25 | Astrazeneca Ab | N-benzyl-morpholine derivatives as modulators of the chemokine receptor |
KR100743617B1 (ko) * | 2005-08-25 | 2007-07-27 | 주식회사 알에스텍 | 고광학순도를 갖는 키랄 3-히드록시 피롤리딘 및 그유도체를 제조하는 방법 |
HUP0500879A2 (en) * | 2005-09-22 | 2007-05-29 | Sanofi Aventis | Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates |
HUP0500886A2 (en) * | 2005-09-23 | 2007-05-29 | Sanofi Aventis | Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use |
HUP0500877A2 (en) * | 2005-09-22 | 2007-05-29 | Sanofi Aventis | Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates |
RU2008115499A (ru) * | 2005-09-22 | 2009-10-27 | Санофи-Авентис (Fr) | Новые производные аминокиламидов в качестве антагонистов лигандов рецепторов ccr3 |
ES2427989T3 (es) | 2005-10-28 | 2013-11-05 | Ono Pharmaceutical Co., Ltd. | Compuesto que contiene un grupo básico y uso del mismo |
PL1961744T3 (pl) | 2005-11-18 | 2013-09-30 | Ono Pharmaceutical Co | Związek zawierający grupę zasadową oraz jego zastosowanie |
CA2644368A1 (en) | 2006-03-10 | 2007-09-20 | Ono Pharmaceutical Co., Ltd. | Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
JP5257068B2 (ja) | 2006-05-16 | 2013-08-07 | 小野薬品工業株式会社 | 保護されていてもよい酸性基を含有する化合物およびその用途 |
WO2008016006A1 (en) | 2006-07-31 | 2008-02-07 | Ono Pharmaceutical Co., Ltd. | Compound having cyclic group bound thereto through spiro binding and use thereof |
WO2010129351A1 (en) | 2009-04-28 | 2010-11-11 | Schepens Eye Research Institute | Method to identify and treat age-related macular degeneration |
CN101906060B (zh) * | 2010-05-06 | 2012-07-04 | 爱斯医药科技(南京)有限公司 | N-取代的3-氨甲基吡咯烷的制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3459757A (en) * | 1965-10-22 | 1969-08-05 | American Cyanamid Co | Imidazolidines |
NZ186175A (en) * | 1977-01-27 | 1980-03-05 | Shionogi & Co | Meta-sulphonamidobenzamide derivatives |
JPS59186969A (ja) * | 1983-04-08 | 1984-10-23 | Yoshitomi Pharmaceut Ind Ltd | ベンゾフラン−およびベンゾピランカルボキサミド誘導体 |
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
JPH01117860A (ja) * | 1987-10-30 | 1989-05-10 | Dainippon Pharmaceut Co Ltd | 安息香酸アミド誘導体 |
JPH02104572A (ja) * | 1988-10-13 | 1990-04-17 | Dainippon Pharmaceut Co Ltd | 安息香酸アミド誘導体 |
US5214055A (en) * | 1990-05-18 | 1993-05-25 | Adir Et Compagnie | Aminopiperidine 4-oxo-4H-chromen-2-yl compounds |
FR2662162B1 (fr) * | 1990-05-18 | 1995-01-20 | Adir | Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
US5254569A (en) * | 1991-01-14 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | (Amidomethyl)nitrogen heterocyclic analgesics |
GB9113031D0 (en) * | 1991-06-17 | 1991-08-07 | Smithkline Beecham Plc | Compounds |
FR2679906B1 (fr) * | 1991-07-31 | 1995-01-20 | Adir | Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
AU2435092A (en) * | 1991-08-20 | 1993-03-16 | Smithkline Beecham Plc | 5-ht4 receptor antagonists |
JPH06212757A (ja) * | 1993-01-19 | 1994-08-02 | Ribaa Kentetsu Kk | ソリ型運搬治具による折板屋根葺き工法 |
EP0742208A1 (en) * | 1995-05-05 | 1996-11-13 | Grelan Pharmaceutical Co., Ltd. | 2-Ureido-benzamide derivatives |
US5827875A (en) * | 1996-05-10 | 1998-10-27 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
EP0916668A4 (en) * | 1996-07-29 | 2000-08-16 | Banyu Pharma Co Ltd | CHEMOKINE RECEPTOR ANTAGONISTS |
IL125658A0 (en) * | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
JPH11140276A (ja) * | 1997-11-11 | 1999-05-25 | Sumitomo Chem Co Ltd | 多官能シアン酸エステル樹脂組成物および樹脂封止型半導体装置 |
WO1999025686A1 (en) * | 1997-11-18 | 1999-05-27 | Teijin Limited | Cyclic amine derivatives and their use as drugs |
-
1999
- 1999-11-11 JP JP2000583860A patent/JP3593037B2/ja not_active Expired - Fee Related
- 1999-11-11 TR TR2001/01398T patent/TR200101398T2/xx unknown
- 1999-11-11 ID IDW00200101080A patent/ID29067A/id unknown
- 1999-11-11 KR KR1020017006362A patent/KR20010086045A/ko not_active Application Discontinuation
- 1999-11-11 WO PCT/EP1999/008665 patent/WO2000031032A1/en not_active Application Discontinuation
- 1999-11-11 CZ CZ20011760A patent/CZ20011760A3/cs unknown
- 1999-11-11 HU HU0104364A patent/HUP0104364A2/hu unknown
- 1999-11-11 PL PL99348375A patent/PL348375A1/xx not_active Application Discontinuation
- 1999-11-11 CA CA002350903A patent/CA2350903A1/en not_active Abandoned
- 1999-11-11 BR BR9915520-6A patent/BR9915520A/pt not_active IP Right Cessation
- 1999-11-11 CN CNB99813287XA patent/CN1158256C/zh not_active Expired - Fee Related
- 1999-11-11 IL IL14322699A patent/IL143226A0/xx unknown
- 1999-11-11 AU AU13825/00A patent/AU763960B2/en not_active Ceased
- 1999-11-11 EP EP99972623A patent/EP1131288A1/en not_active Withdrawn
- 1999-11-16 PE PE1999001161A patent/PE20001403A1/es not_active Application Discontinuation
- 1999-11-17 GB GB9927227A patent/GB2343893B/en not_active Expired - Fee Related
- 1999-11-18 US US09/442,656 patent/US6166015A/en not_active Expired - Fee Related
- 1999-11-18 AR ARP990105860A patent/AR023707A1/es unknown
- 1999-11-18 FR FR9914495A patent/FR2786185A1/fr not_active Withdrawn
- 1999-11-18 CO CO99072639A patent/CO5140119A1/es unknown
- 1999-11-19 IT IT1999TO001009A patent/IT1307900B1/it active
- 1999-11-19 ES ES009902547A patent/ES2158814B1/es not_active Withdrawn - After Issue
- 1999-11-19 DE DE19955794A patent/DE19955794A1/de not_active Withdrawn
- 1999-11-19 UY UY25811A patent/UY25811A1/es unknown
-
2001
- 2001-05-15 ZA ZA200103942A patent/ZA200103942B/en unknown
- 2001-05-16 NO NO20012411A patent/NO20012411L/no not_active Application Discontinuation
- 2001-05-17 MA MA26199A patent/MA26762A1/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9915520A (pt) | Antagonistas receptores ccr-3 derivados de pirrolidina | |
BR0014133A (pt) | Uso de um composto, composto, métodos de preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica | |
BR0009703A (pt) | Compostos ou sais, ou composições uso dos mesmos, e, formulações farmacêuticas | |
BR0307409A (pt) | Compostos de hidrazida de ácido 2-furanocarboxìlico, composições farmacêuticas contendo os mesmos e uso dos mesmos para preparação de um agente preventivo ou terapêutico | |
BR0009702A (pt) | Compostos ou seus sais, uso de compostos ou sais, e, formulações farmacêuticas | |
BRPI9608082B8 (pt) | derivado de quinazolina, sal de cloridreto do mesmo, e, composição farmacêutica | |
BR0306150A (pt) | Composto, uso de um composto, e, composição farmacêutica | |
BR9913592A (pt) | Compostos, processo de preparação dos compostos, e, composições farmacêuticas | |
BR0110267A (pt) | Inibidores de dipeptidil peptidase iv | |
DE69706642T2 (de) | Pyridylfuran- und Pyridylthiphenderivate und deren pharmazeutische Verwendung | |
BR0009007A (pt) | Derivados de piperidina, tetraidropiridina epiperazina; composto; composição farmacêutica;utilização e método | |
KR970701722A (ko) | 포스폰산 디에스테르 유도체(phosphonic diester derivative) | |
BR9914370A (pt) | Derivados de tetraidrobenzazepina úteis comomoduladores de receptores para a dopamina d3(agentes antipsicóticos) | |
KR870003974A (ko) | 비시클로 치환된 페닐아세토니트릴 유도체 | |
BR9807279A (pt) | Composições aditivas de lavanderia acrescidas de enxaguante contendo agentes protetores de cor | |
Olmsted et al. | A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic. kappa. address element to the. delta. antagonist, natrindole: 5'-[(N2-alkylamidino) methyl] naltrindole derivatives as a novel class of. kappa. opioid receptor antagonists | |
BR9801744A (pt) | Derivados 5-deóxi citimida | |
BR0100234A (pt) | Compostos de piperidina-4-sulfonamida, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
BR0012475A (pt) | Compostos de titânio, preparação e utilização dos mesmos | |
KR890014107A (ko) | 백금 화학 요법약제 | |
EA200200232A1 (ru) | Интерлейкин-5 ингибирующие производные 6-азаурацила | |
BR9714215A (pt) | Derivados de benzoato de 1,4-diazabiciclo[2.2.2]oct-2-ilmetila, seu preparo e sua aplicação em terapêutica | |
BR9911057A (pt) | Azóis solúveis em água como antifúngicos de amplo espectro | |
TR200000153T2 (tr) | İl-5 inhibite eden 6-azaurasil türevleri. | |
BR0111216A (pt) | Misturas de estabilizadores |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1954 DE 17/06/2008. |